Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital ...Sanjay Jaiswal
We are presenting our personal experience regarding thrombolytic therepy in ac ischaemic stroke patients at jaiswal hospital and neuro institute ,kota,Rajasthan,INDIA
Stroke is a medical emergency, with a mortality rate higher
than most forms of cancer. It is the second leading cause of
death in developed countries and is the most common cause
of serious, long-term disability in adults. The incidence of
stroke is increasing with the aging of populations and hence
there is a major challenge to health planners.
Stroke prevention for nonvalvular AF, summary of evidence-based guidelinesErsifa Fatimah
Ternyata... guideline yang ngebahas prevensi stroke pada nonvalvular AF tu banyak banget! Yang dirilis komunitas Neuro maupun Cardio, yang internasional maupun yang lokal. Dan pertanyaan besarnya tetep: What's the best strategy?
*Bonus special issue: manajemen prevensi stroke infark dengan antikoagulan pasca brain hemorrhage.
Acute stroke management
IV thrombolysis guidelines
IV thrombolysis side effects
Early CT changes in stroke
ASPECTS scoring
AHA stroke guidelines
Thrombolysis controversies
Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital ...Sanjay Jaiswal
We are presenting our personal experience regarding thrombolytic therepy in ac ischaemic stroke patients at jaiswal hospital and neuro institute ,kota,Rajasthan,INDIA
Stroke is a medical emergency, with a mortality rate higher
than most forms of cancer. It is the second leading cause of
death in developed countries and is the most common cause
of serious, long-term disability in adults. The incidence of
stroke is increasing with the aging of populations and hence
there is a major challenge to health planners.
Stroke prevention for nonvalvular AF, summary of evidence-based guidelinesErsifa Fatimah
Ternyata... guideline yang ngebahas prevensi stroke pada nonvalvular AF tu banyak banget! Yang dirilis komunitas Neuro maupun Cardio, yang internasional maupun yang lokal. Dan pertanyaan besarnya tetep: What's the best strategy?
*Bonus special issue: manajemen prevensi stroke infark dengan antikoagulan pasca brain hemorrhage.
Acute stroke management
IV thrombolysis guidelines
IV thrombolysis side effects
Early CT changes in stroke
ASPECTS scoring
AHA stroke guidelines
Thrombolysis controversies
Effect of Blood Pressure Lowering in Early Ischemic Stroke, Time to Change Pr...Ersifa Fatimah
Seorang rekan residen neuro sampai mengirim (via e-mail) sebuah jurnal yang baru ditelaahnya di larut malam. Kepada si cip, dia menyatakan bagaimana jurnal ini membuat pikirannya bergejolak, “Seperti dipaksa untuk menerima sebuah pemikiran baru yang melawan apa yang telah kita yakini bersama dalam proses belajar kita selama 5 tahun terakhir ini!”
Artikel itu berjudul Effect of Blood Pressure Lowering in Early Ischemic Stroke: Meta-Analysis oleh Lee et al., dan dipublikasi dalam jurnal Stroke Juli 2015.
There is a Primary Prevent Indication in Diabetes | Mubashar A ChoudryMubashar A Choudry MD
Dr. Mubashar A Choudry, MD, is proud to serve patients at Washington Vascular Specialists, the first outpatient vascular treatment center in the mid-Atlantic region, with locations in Takoma Park, Largo, and Frederick, Maryland. He is a specialist in cardiology medical field.
Managing Stroke risk in Atrial Fibrillation: Are we fulfilling our potential?
Presented by Mel Varvel - NHS Improving Quality and Marion Kerr - Insight Health Economics at National Association of Primary Care ‘Best Practice’ Conference in Birmingham, October 2013
GRASP-AF tool: Identifies patients with a history of atrial fibrillation
Searches for co-morbidities and calculates a CHADS2 (and now CHA2DS2-VASc) score
Searches for current medication- warfarin, aspirin or newer oral anticoagulant
Searches for recorded reasons for NOT treating with OAC
Gives a simple alert for those at high risk and not on warfarin or newer oral anticoagulant
Debra K. Katzman, MD ABSTRACT The purpose of the current article .docxedwardmarivel
Debra K. Katzman, MD* ABSTRACT The purpose of the current article is to summarize the evidence-based medical complications and treatments that are both common and unique to adolescents with anorexia nervosa (AN). Recent literature relating to the cardiovascular complications,refeedingsyndrome, alterations in linear growth, impaired bone mineralaccretion,and structuralandfunctional brain changes was reviewed. The literature suggests that the medical complications in adolescents with AN are different from those reported in adults. The unique clinical presentation, the early onset, and the unknown impact of these
complications underscore the need for early identification and treatment of AN in adolescents. AN is a serious disorder with significant and often life-threatening medical complications. The increasing growth of evidence highlights the importance of early identification and treatment by an interdisciplinary team of health care providers who have expertise in managing adolescents with AN and their medical sequelae. ª 2005 by Wiley Periodicals, Inc.
Keywords: medical complications; adolescents; anorexia nervosa
(Int J Eat Disord 2005; 37:S52–S59
Introduction
Anorexia nervosa (AN) in adolescents can cause significant medical complications in every organ system in the growing and developing body.1 Critical to the ongoing advancement of our understanding of AN in adolescents is the steady growth of evidence on the identification and management of the multitude of medical complications. Although many of these medical complications improve with nutritional rehabilitation and recovery from the eating disorder, some are potentially irreversible. As such, the long-term implications of these medical complications that typically begin in the formative years of adolescence are unknown. The current article summarizes the evidence-based literature on common medical complications that have been specifically studied in adolescent populations with AN over the past 20 years. We will focus on the cardiovascular and metabolic complications with a particular emphasis on refeeding syndrome, alterations in linear growth, impaired bone mineral accretion, and reference to structural and functional brain
changes, all of which have been studied in adolescents with AN.
Cardiovascular Complications
AN is a life-threatening condition, with significant risk of death due to cardiac complications. One third of the deaths in adults with eating disorders are due to cardiac complications.2 There are no such data regarding adolescents with AN. Cardiac involvement is present in the early stages of the disorder in adolescents with AN.3,4 In fact, even with a short duration of illness, there are both functional and structural cardiac abnormalities that appear to be reversible with early identification and treatment.3 Upon reviewing the adolescent eating disorder literature, the most common reported cardiovascular complications include electrocardiographic abnormalities such as.
Renal function is greatly important in risk stratification, pharmacologic therapy, and the prognosis of patients with heart failure (HF).
The deterioration of heart function can result in the worsening renal function (WRF) and vice versa.
Besides the heart function itself, the Pharmacologic Treatment of HF is closely related to renal function as regards initiation, titration, and discontinuation, making the situation more complex.
Update on Fabry disease findings and the heart.
Update on cardiac predictors in Fabry disease.
Update on imaging in Fabry disease.
Update on comprehensive cardiovascular care in Fabry disease.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Guia AHA/ACC STROKE 2014
1. DR. ROBERTO MEDINA R3 MEDICINA INTERNA
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
2. TIA / STROKE
• Mas de 690 mil casos anuales de ICTUS EE.UU
• Mas de 240 mil casos anuales de TIA EE.UU
• Riesgo de ICTUS después de un TIA o ICTUS previo es 3-4% anual
historica %
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
3. Definiciones
Aterosclerosis
de grandes
vasos
Ictus
Isquemico
cardioembólica
Causas
secundarias e
indeterminadas
Enfermedad de
pequeños vasos
• TIA
• vs
• ICTUS
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
4. Objetivos
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
5. Novedades
• Nuevos factores de riesgo: Apnea del sueño, aterosclerosis arco
aórtico, nutrición, pre-diabetes.
• Revisión FA, estenosis carotidea, válvulas protésicas cardiacas con
relación a AHA y ACC
• Consideración del ¨infarto cerebral silente¨
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack, Stroke AHA ,May 1, 2014
6. Secciones
• Hipertensión
• Dislipidemia
• Diabetes mellitus
• Obesidad
• Inactividad física
• Nutrición
• Apnea del sueño
• Tabaco
• Alcohol
• Enfermedad carotidea
• Embarazo
• Aterosclerosis intracraneal
• Fibrilación auricular
• Miocardiopatía
• Enfermedad valvular
• PFO
• Homocisteinemia
• Antiagregantes plaquetarios
• Hipercoagulación
• Anticuerpos antifosfolipidos
• Falcemia
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
7. Hipertensión Arterial
78 millones de estadounidenses
sufren de HTA
Objetivo preventivo mas importante
Prevalencia HTA/ICTUS reciente
70%
Walter N. Kernan et, al Guidelines for the Prevention of Stroke
in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
8. Placebo vs perindopril+indapamida
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
9. Capp Trial
Lennart Hansson, Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in
hypertension: the Captopril Prevention Project (CAPPP), THE LANCET • Vol 353 • February 20, 1999
10. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA
,May 1, 2014
11. Dislipidemia
La “ACC/AHA Guideline on the Treatment of Blood
Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in
Adults” fue lanzada en el 2013
Reemplaza la ATP III
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
12. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
13. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
14. Trastornos del metabolismo de la glucosa
• Notable aumento
tanto en países
desarrollados como
en vía de desarrollo
• 11.3% de adultos EEUU
Actualmente Dx.
Walter N. Kernan et, al Guidelines for the Prevention of Stroke
in Patients With Stroke and Transient Ischemic Attack,Stroke
AHA ,May 1, 2014
15. Px. con ictus isquémico reciente uso del activo RR 45% con relacion a placebo
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
16. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
17. Obesidad
IMC mayor 30kg/m2
Factor de riesgo asociado
a dislipidemia, SM, DM y HTA
Relacion lineal:
IMC/ACV= 1kg/m2=5% ACV
Obesidad central/ACV
Px. ACV o AIT=Dx. 18-44%
obesos
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke
AHA ,May 1, 2014
18. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May
1, 2014
19. Inactividad física
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
20. 2013 AHA/ACC Guideline on Lifestyle
Management to Reduce
Cardiovascular Risk
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
21.
22. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
23. Nutrición
Enfoque: Desnutrición/equilibrio de micronutrientes/dieta óptima
Prevalencia 8-13% niveles de vit D/K Pescado/hortalizas/mediterranea
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
24. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack, Stroke AHA ,May 1, 2014
25. • Apnea del sueño
¾ de Px. con Ictus
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
26. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
27. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
28. Enfermedad carotidea
Data from the North American Symptomatic Carotid Artery Trial
(NASCET)
Figure
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
29. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
30. Aterosclerosis intracraneal
Causa mas importante de AIT/ICTUS
Sin diferencias significativas
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
31. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
32. Walter N. Kernan et, al Guidelines for the Prevention of Stroke
in Patients With Stroke and Transient Ischemic Attack,Stroke
AHA ,May 1, 2014
33. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
34. Fibrilación auricular
• Afecta mas de 2.7 millones en EE.UU
• A mayor edad mayor prevalencia/ arritmia mas frecuente en los
ancianos
• Responsable de mas de 70 mil ictus isquémico por año en EE.UU (10%)
• Estimación riesgo
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
35. Eficacia de la anticoagulación
Warfarina:
EAFT
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
36. ACTIVE-W TRIAL
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
37. NUEVOS ANTICOAGULANTES?
Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
38. Walter N. Kernan et, al Guidelines for the Prevention of Stroke
in Patients With Stroke and Transient Ischemic Attack,Stroke
AHA ,May 1, 2014
39. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014
40. Walter N. Kernan et, al Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack,Stroke AHA ,May 1, 2014